• InterView
• Takeda, “Alunbrig improved both OS and QoL”
• by Jul 8, 2021 05:58am

• Company
• Chong Kun Dang loses 1st substance patient suit on ‘Xarelto
• by Kim, Jin-Gu Jul 8, 2021 05:58am

• Company
• GC Pharma, the most likely company to produce Covivak
• by Nho, Byung Chul Jul 8, 2021 05:58am

• Company
• Y-Biologics has transferred anti-cancer drug technology
• by An, Kyung-Jin Jul 8, 2021 05:58am

• Company
• MFDS in a month-long silence regarding Champix issue
• by Jul 7, 2021 05:54am

• Company
• [Reporter's view] Korean patients to name specific drugs
• by Eo, Yun-Ho Jul 7, 2021 05:54am

• Policy
• Generic prices are 41-54% more expensive than foreign ones
• by Lee, Hye-Kyung Jul 7, 2021 05:53am

• Product
• Consult with MD about controversy over Champix?
• by Jul 7, 2021 05:53am

• Policy
• ‘Immunoglobulin inj’ is reimbursed for vaccine-related TTS
• by Lee, Hye-Kyung Jul 7, 2021 05:52am

• Company
• The NPS bought shares in Samsung BioLogics & SK Bio
• by Kim, Jin-Gu Jul 6, 2021 05:51am